MCK
McKesson Corporation · NYSE · Healthcare · USD · 10-K for 2026, filed 2026-05-08
Figures on this page computed 2026-11-08 12:33 UTC
Last close
1,069.44USD
Market data, 2026-11-04
Except where said otherwise: 10-K for 2026, filed 2026-05-08
27.5xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Fiscal year
- 2026
- Accession
- 0000927653-26-000069
- Reported in
- USD
- computed
- 10-K for 2026, filed 2026-05-08
192.3%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Fiscal year
- 2026
- Accession
- 0000927653-26-000069
- Reported in
- USD
- 10-K for 2026, filed 2026-05-08
- 10-K for 2026, filed 2026-05-08
- 10-K for 2026, filed 2026-05-08
- 10-Q for 2026, filed 2026-08-05
- 10-K for 2026, filed 2026-05-08
- 10-Q for 2026, filed 2026-08-05
1.2%Net margin
Net Income / Revenue x 100
- Source
- computed
- Fiscal year
- 2026
- Accession
- 0000927653-26-000069
- Reported in
- USD
- 10-K for 2026, filed 2026-05-08
- 10-K for 2026, filed 2026-05-08
1.4%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Fiscal year
- 2026
- Accession
- 0000927653-26-000069
- Reported in
- USD
- 10-K for 2026, filed 2026-05-08
- 10-K for 2026, filed 2026-05-08
n/aDebt/equity
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
- Source
- computed
- Fiscal year
- 2026
- Accession
- 0000927653-26-000069
- Reported in
- USD
- 10-K for 2026, filed 2026-05-08
- 10-Q for 2026, filed 2026-08-05
0.3%Dividend yield
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- USD
- computed
- computed
- computed
- computed
- computed
- Computed from the filing for 2026, filed 2026-05-08
Margins is the furthest below its sector's middle: 0.36 against 0.36 on the market's range.
Against its rival
lens 4 of 9Measure by measure
behind on 1 of 5- Profit on each unit of sales1.2%0.4%Ahead
Higher is better here.
- Return on the capital it uses192%2.6%Ahead
Higher is better here.
- Sales growth over five years11.1%8.4%Ahead
Higher is better here.
- Debt against equityn/a1.08n/a
Lower is better here.
- Gross margin3.6%45.0%Behind
Higher is better here.
- Price against earnings27.5x59.9xAhead
Lower is better here.
The first column is this company and the second is the one it is set against. A measure only one of the two reports is left at n/a rather than counted as a win.
Against CVS Health Corporation, MCK is behind on 1 of 5 measures.
Against CVS Health Corporation, MCK is behind on 1 of 5 measures.
Every figure in this lens
Except where said otherwise: 10-K for 2026, filed 2026-05-08
Profit on each unit of sales1.2%
- Source
- filed
- Statement
- income
- Fiscal year
- 2026
- Accession
- 0000927653-26-000069
- Reported in
- USD
Return on the capital it uses192.3%
- Source
- filed
- Statement
- income
- Fiscal year
- 2026
- Accession
- 0000927653-26-000069
- Reported in
- USD
Sales growth over five years11.1%
- Source
- filed
- Statement
- income
- Fiscal year
- 2026
- Accession
- 0000927653-26-000069
- Reported in
- USD
Debt against equityn/a
Not held.
- Source
- filed
- Statement
- income
- Fiscal year
- 2026
- Accession
- 0000927653-26-000069
- Reported in
- USD
Gross margin3.6%
- Source
- filed
- Statement
- income
- Fiscal year
- 2026
- Accession
- 0000927653-26-000069
- Reported in
- USD
Price against earnings27.5x
- Source
- filed
- Statement
- income
- Fiscal year
- 2026
- Accession
- 0000927653-26-000069
- Reported in
- USD